首页> 外文期刊>Bone marrow transplantation >Successful treatment of intravascular malignant lymphomatosis with high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
【24h】

Successful treatment of intravascular malignant lymphomatosis with high-dose chemotherapy and autologous peripheral blood stem cell transplantation.

机译:大剂量化疗和自体外周血干细胞移植成功治疗血管内恶性淋巴瘤病。

获取原文
获取原文并翻译 | 示例
           

摘要

Intravascular malignant lymphocytosis (IML) is a rare systemic disease characterized by proliferation of malignant B (rarely T) lymphoid cells within the lumina of small arteries, veins, and capillaries. Diagnosis requires skin, liver, renal, meningeal, or brain biopsy, but is rarely made ante mortem. In this report, we describe a patient who had an ante mortem diagnosis of IML as a result of a skin biopsy. Autologous peripheral blood stem cell transplantation (auto-PBSCT) was successfully performed after chemotherapy. The patient has survived for more than 30 months since the onset of the disease and maintains complete remission on the 450th day post PBSCT. To our knowledge, this is the first case of IML treated by auto-PBSCT.
机译:血管内恶性淋巴细胞增多症(IML)是一种罕见的全身性疾病,其特征是小动脉,静脉和毛细血管腔内的恶性B(罕见T)淋巴样细胞增殖。诊断需要皮肤,肝,肾,脑膜或脑活检,但很少进行事前验尸。在本报告中,我们描述了由于皮肤活检而对IML进行事前诊断的患者。化疗后成功进行了自体外周血干细胞移植(auto-PBSCT)。自该病发作以来,该患者已存活超过30个月,并在PBSCT后第450天保持完全缓解。据我们所知,这是auto-PBSCT治疗IML的第一例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号